Three-vessel spontaneous coronary artery dissection in a patient with hyperhomocysteinemia

Christos S Katsouras1, Michail I Papafaklis1, Lampros Lakkas1

  • 12nd Department of Cardiology, University Hospital of Ioannina, Ioannina, Greece.

Insights

This case study highlights a rare instance of three-vessel spontaneous coronary artery dissection (SCAD) in a young male. The patient remained clinically stable despite extensive SCAD, linked to hyperhomocysteinemia and a genetic mutation.

Area of Science:

  • Cardiology
  • Genetics
  • Vascular Biology

Background:

  • Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndrome, particularly in younger individuals.
  • Long-term follow-up data for SCAD patients are scarce, limiting understanding of its natural history.
  • Elevated homocysteine levels are implicated in arterial dissections, including coronary and cervical arteries.

Observation:

  • A young male presented with a rare case of three-vessel SCAD, characterized by dissections in all three major coronary arteries.
  • The patient exhibited hyperhomocysteinemia and a methylenetetrahydrofolate reductase (MTHFR) prothrombotic mutation.
  • Despite extensive multi-vessel SCAD, the patient demonstrated long-term clinical stability of coronary artery disease.

Findings:

  • Multi-vessel SCAD, though rare, can be associated with specific genetic predispositions like MTHFR mutations.
  • Hyperhomocysteinemia may be a significant contributing factor in the pathogenesis of SCAD.
  • Angiographic evidence of SCAD does not always correlate with immediate clinical deterioration.

Implications:

  • Familiarity with the angiographic appearance of multi-vessel SCAD is crucial for accurate diagnosis.
  • Identifying genetic factors like MTHFR mutations and metabolic conditions like hyperhomocysteinemia can aid in risk stratification for SCAD.
  • The potential for long-term clinical stability in some SCAD patients warrants further investigation into prognostic factors and management strategies.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
69
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
244
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
53
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
163